Accuray President and Chief Executive Officer Suzanne Winter Returns from Medical Leave of Absence
Accuray Incorporated (NASDAQ: ARAY) announced that Suzanne Winter has returned from her temporary medical leave and resumed her full duties as President and Chief Executive Officer, effective October 15, 2024. Sandeep Chalke, who served as interim CEO during Winter's absence, will continue in his role as Senior Vice President and Chief Commercial Officer.
Joseph Whitters, Chairman of the Board at Accuray, expressed delight at Winter's return and appreciation for Chalke's leadership during her absence. Accuray, headquartered in Madison, Wisconsin, is committed to expanding the potential of radiation therapy in oncology and neuro-radiosurgery, focusing on innovative solutions for complex and common cases alike.
Accuray Incorporated (NASDAQ: ARAY) ha annunciato che Suzanne Winter è tornata dal suo congedo medico temporaneo e ha ripreso le sue piene funzioni come Presidente e Amministratore Delegato, a partire dal 15 ottobre 2024. Sandeep Chalke, che ha ricoperto il ruolo di CEO ad interim durante l'assenza di Winter, continuerà nel suo incarico di Vicepresidente Senior e Direttore Commerciale.
Joseph Whitters, Presidente del Consiglio di Amministrazione di Accuray, ha espresso la sua gioia per il ritorno di Winter e il suo apprezzamento per la leadership di Chalke durante la sua assenza. Accuray, con sede a Madison, Wisconsin, è impegnata ad ampliare il potenziale della terapia radiante in oncologia e nella neurochirurgia radiologica, concentrandosi su soluzioni innovative per casi complessi e comuni.
Accuray Incorporated (NASDAQ: ARAY) anunció que Suzanne Winter ha regresado de su licencia médica temporal y ha reanudado sus plenas funciones como Presidenta y Directora Ejecutiva, a partir del 15 de octubre de 2024. Sandeep Chalke, quien se desempeñó como CEO interino durante la ausencia de Winter, continuará en su rol como Vicepresidente Sénior y Director Comercial.
Joseph Whitters, Presidente de la Junta de Accuray, expresó su alegría por el regreso de Winter y su agradecimiento por el liderazgo de Chalke durante su ausencia. Accuray, con sede en Madison, Wisconsin, está comprometida en expandir el potencial de la terapia de radiación en oncología y neurocirugía radiológica, enfocándose en soluciones innovadoras para casos complejos y comunes.
Accuray Incorporated (NASDAQ: ARAY)는 Suzanne Winter가 일시적인 의료 휴가에서 복귀하여 회장 및 CEO로서의 모든 임무를 재개했다고 발표했습니다. 이는 2024년 10월 15일부터 효력이 발생합니다. Winter 부재 중에 임시 CEO로 활동했던 Sandeep Chalke는 선임 부사장 겸 상업 책임자로서의 역할을 계속 수행할 것입니다.
Accuray의 이사회 의장인 Joseph Whitters는 Winter의 복귀에 기쁜 마음을 표현하며 Chalke의 리더십에 감사의 뜻을 전했습니다. Wisconsin주 Madison에 본사를 둔 Accuray는 온콜로지 및 신경 방사 수술에서 방사선 치료의 가능성을 확장하는 데 전념하며, 복잡하고 일반적인 사례에 대한 혁신적인 솔루션에 집중하고 있습니다.
Accuray Incorporated (NASDAQ: ARAY) a annoncé que Suzanne Winter était de retour de son congé médical temporaire et avait repris ses fonctions complètes en tant que Présidente et Directrice Générale, à compter du 15 octobre 2024. Sandeep Chalke, qui a été PDG par intérim pendant l'absence de Winter, continuera dans son rôle de Vice-Président Senior et Directeur Commercial.
Joseph Whitters, Président du Conseil d'Administration d'Accuray, a exprimé sa joie au retour de Winter et sa reconnaissance pour le leadership de Chalke durant son absence. Accuray, dont le siège est à Madison, Wisconsin, s'engage à élargir le potentiel de la radiothérapie en oncologie et en neurochirurgie radiologique, en se concentrant sur des solutions innovantes pour des cas complexes et courants.
Accuray Incorporated (NASDAQ: ARAY) gab bekannt, dass Suzanne Winter von ihrem vorübergehenden medizinischen Urlaub zurückgekehrt ist und ihre vollen Aufgaben als Präsidentin und Geschäftsführerin wieder aufgenommen hat, wirksam ab dem 15. Oktober 2024. Sandeep Chalke, der während Winters Abwesenheit als Interims-CEO fungierte, wird weiterhin in seiner Rolle als Senior Vice President und Chief Commercial Officer tätig sein.
Joseph Whitters, Vorsitzender des Aufsichtsrats von Accuray, äußerte seine Freude über Winters Rückkehr und seinen Dank für Chalke's Führung während ihrer Abwesenheit. Accuray mit Sitz in Madison, Wisconsin, engagiert sich dafür, das Potenzial der Strahlentherapie in der Onkologie und der neurochirurgischen Radiotherapie zu erweitern und konzentriert sich auf innovative Lösungen für komplexe und alltägliche Fälle.
- CEO Suzanne Winter has returned from medical leave, resuming full duties
- Continuity in leadership with Sandeep Chalke returning to his previous role
- None.
"On behalf of the entire Board of Directors, I am delighted Suzanne has resumed her role as CEO. We appreciate the leadership provided by Sandeep in her absence and the support of the global Accuray team," said Joseph Whitters, Chairman of the Board at Accuray.
About Accuray
Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions designed to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in
Investor Contact
Aman Patel, CFA
Investor Relations, ICR-Westwicke
+1 (443) 450-4191
aman.patel@westwicke.com
Media Contact
Beth Kaplan
Public Relations Director, Accuray
+1 (408) 789-4426
bkaplan@accuray.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/accuray-president-and-chief-executive-officer-suzanne-winter-returns-from-medical-leave-of-absence-302276241.html
SOURCE Accuray Incorporated
FAQ
When did Suzanne Winter return as CEO of Accuray (ARAY)?
Who served as interim CEO of Accuray (ARAY) during Suzanne Winter's absence?
What is Accuray's (ARAY) primary focus in the medical field?
Where is Accuray (ARAY) headquartered?
